4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001628280-25-004085
Chief Executive Officer gave up 5,569 shares (to pay taxes)
- Chief Executive Officer acquired 542,092 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gibson Christopher Chief Executive Officer | 2025-02-03 | Grant or award | +525,283 | 1,261,916 | D: show line 1 in the form | ||
| Gibson Christopher Chief Executive Officer | 2025-02-03 | Grant or award | +16,809 | 1,278,725 | D: show line 2 in the form | ||
| Gibson Christopher Chief Executive Officer | 2025-02-03 | Shares withheld for taxes | −5,569 | $7.25 | $40,375 | 1,273,156 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Gibson Christopher Chief Executive Officer | 2025-02-03 | Grant or award · Stock Option (Right to Buy) | +1,050,567 | 1,050,567 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1738792209.xml…